Constellation Pharmaceuticals Reaches Analyst Target Price
November 07, 2019 at 08:39 AM EST
In recent trading, shares of Constellation Pharmaceuticals Inc (CNST) have crossed above the average analyst 12-month target price of $17.33, changing hands for $28.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..